Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Daniel Pryma, Bennett Chin, Richard Noto, Joseph Dillon, Lilja Solnes, Theresa White, Nancy Stambler, Tess Lin, Vincent A. DiPippo, Jessica Donato Jensen, Syed Mahmood, Vivien Wong, Camilo Jimenez | ||||||||||||
Title | Azedra (iobenguane I 131) in patients with malignant, recurrent and/or unresectable pheochromocytoma or paraganglioma (PPGL): Updated efficacy and safety results from a multi-center, open-label, pivotal phase 2 study. | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/214/AbstView_214_229729.html | ||||||||||||
Abstract Text | J Clin Oncol 36, 2018 (suppl; abstr 4005) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|